HIV molecular immunology database
| Patient Code | 014A-005 |
|---|---|
| Patient Sex | Male |
| Risk Factor | Sex with male (SM) |
| Infection Country | US |
| Infection City | |
| Infection Year | |
| HLA Type | A*25:01, A*30:02, B*07:02, B*18:01, C*07:02, C*12:03 |
| Patient Ethnicity | White |
| Progression | |
| Species | human |
| Patient Note | Subject 014A-005, 43 years old, who participated in a vaccine trial, acquired HIV within 392 days of administration of vaccine vCP205/gp120, 4 times. Response to epitopes Gag QAISPRTLNAW, Gag ETINEEAAEW, Env TENFNMWKNNMVEQM, Env IPRRIRQGL, Nef FPVTPQVPLR, Tat CCFHCQVC, Pol QKQGQGQWTYQIYQE, Pol KIQNFRVYY and Vpr EAVRHFPRIWLHGLG by EliSpot was358, 363, 585, 943, 558, 408, 165, 435 and 490 SFC/106 PBMC, 71d post-infection (dpi). [Horton2006a, PMID: 16973582]. Additional HLA-C alleles from authors (pers comm., J.McNevin, 2021). |
| CTL CD8+ Records | 54919, 54921, 54922, 54923, 54924, 54925, 54926, 54927, 54928 |
| T-Helper CD4+ Records | |
| Antibody Records | |
| Sequence Database Patient ID Record |